Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed Apr 1, 2024 · 10-K · 92 days after period end · 0001091818-24-000034
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$114.41K | -$114.74K | -$120.70K | -$122.57K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 1, 2024 · 92 d after period end